Presentations Details
Poster Presentation (Abstract 1726)
Title: Effect of investigational, live biotherapeutic, SER-155, on gastrointestinal (GI) microbiome composition in adults receiving allogeneic haematopoietic stem cell transplant (allo-HCT) in a randomised, placebo-controlled phase 1b trial
Session: PS073 – 10c: Infections related to haematopoietic stem cell transplantation
Date and Time: Sunday, February 19 at 12:00 CEST
Presenter: Dr. Elizabeth Halvorsen, Senior Director, Translational Biology at Seres Therapeutics
Oral Presentation (Abstract 8914)
Title: Recapturing individual inflammatory responses in IBD microbiomes using an in vitro colonic model (MiGut)
Session: OS100: Microbiome-host interplay in intestinal disease and under selection pressure
Date and Time: Monday, April 20 at 14:45 CEST
Presenter: Dr. Ines Moura, Lecturer in Medical Microbiology at the University of Leeds
Symposium Presentation
Title: Targeting the gut microbiome: an emerging trend in haematopoietic stem cell transplantation
Session: 10. Immune compromise & transplant ID - The role of the microbiome in shaping clinical outcomes in immunocompromised patients
Date and Time: Tuesday, April 21 at 8:30 CEST
Presenter: Dr. Jonathan (Tsoni) Peled, Bone Marrow Transplant Specialist at MSKCC
Login to comment